Close Menu

NEW YORK (GenomeWeb) – Veracyte reported after the close of the market on Tuesday that its fourth quarter 2017 revenues increased 7 percent compared to the fourth quarter 2016.

For the three months ended Dec. 31, 2017, the genomic testing firm reported total revenues of $19.6 million, compared to $18.3 million in Q4 2016, and just beating the analysts' average estimate of $19.0 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
30
Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.